CardioComm Solutions, Inc. Stock OTC Markets

Equities

EKGGF

CA14159N2086

Advanced Medical Equipment & Technology

Delayed OTC Markets 09:54:11 2024-05-02 am EDT 5-day change 1st Jan Change
0.0038 USD -47.95% Intraday chart for CardioComm Solutions, Inc. -47.95% -62.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 996K 725K Sales 2023 876K 638K Capitalization 1.51M 1.1M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 4.08 x
Net Debt 2022 288K 210K Net Debt 2023 398K 290K EV / Sales 2023 2.18 x
P/E ratio 2022
-1,563 x
P/E ratio 2023
-15.6 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 61.88%
More Fundamentals * Assessed data
Dynamic Chart
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
CardioComm Solutions, Inc. Appoint Robin Black to Board of Directors CI
Cardiocomm Solutions, Inc. Announces CFO Changes CI
CardioComm Solutions, Inc. Resumes Full Operations Following Cyber Attack CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
CardioComm Solutions, Inc. Announces Executive Changes CI
CardioComm Solutions, Inc. Confirms Technology Integration Agreement with Utah-Based Carexm LLC CI
CardioComm Solutions, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
CardioComm Solutions, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
CardioComm Solutions, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
CardioComm Solutions, Inc. Auditor Raises 'Going Concern' Doubt CI
CardioComm Solutions, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day-47.95%
1 week-47.95%
Current month-47.95%
1 month-47.95%
3 months-47.95%
6 months-62.00%
Current year-62.00%
More quotes
1 week
0.00
Extreme 0.0038
0.00
1 month
0.00
Extreme 0.0038
0.00
Current year
0.00
Extreme 0.0006
0.01
1 year
0.00
Extreme 0.0006
0.01
3 years
0.00
Extreme 0.0006
0.05
5 years
0.00
Extreme 0.0006
0.09
10 years
0.00
Extreme 0.0006
0.10
More quotes
Managers TitleAgeSince
Chief Executive Officer - 06-11-28
Chairman - 15-12-15
Chief Tech/Sci/R&D Officer - 14-08-05
Members of the board TitleAgeSince
Chief Executive Officer - 06-11-28
Chairman - 15-12-15
Director/Board Member - -
More insiders
Date Price Change Volume

Delayed Quote OTC Markets, May 02, 2024 at 09:54 am EDT

More quotes
CardioComm Solutions, Inc. is a Canada-based company, which develops software, hardware and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets globally. The Company's specialization is in the software engineering of computer based (ECG) management and reporting software. The software permits physician interpretations of ECGs and supports private and public payer fee-for-service billings. The Company’s device connectivity and ECG management technologies are used in medical, consumer, clinical research and telemedicine solutions for the recording, transmission, viewing, analyzing, reporting and storage of electrocardiograms, for arrhythmia screening, diagnosis, and management of cardiac patients. Its Global ECG Management Solutions (GEMS) and GlobalCardio (Cloud based GEMS) products are licensed worldwide to hospitals, ECG commercial reading services and physicians.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW